Participants:18–64 years · 65+ years
Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate

Contact Research Centre

Colitis ulcerative

Recruiting

InvestigationalNo placebo

Efficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Golimumab

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Nivolumab, Pembrolizumab, and Cemiplimab with Radiotherapy for Stage IV Non-Small Cell Lung Cancer Patients

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Crohn's disease

Recruiting

Investigational

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Deafness neurosensory

Recruiting

Registered drugNo placebo

Study of Hyperbaric Oxygen Therapy Combined with Standard Treatment for Patients with Sudden Hearing Loss

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Nitrous Oxide

Contact Research Centre

Diffuse large B-cell lymphoma refractory

Not yet recruiting

Registered drugNo placebo

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo

Norway

Participants:65+ years
Substances:Cyclophosphamide

Contact Research Centre

Primary adrenal insufficiency

Not recruiting

Registered drugNo placebo

Study on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone

Registered drugNo placebo

Norway

Participants:0–17 years · 18–64 years
Substances:Cortisone

Contact Research Centre

Lung neoplasm malignant

Not recruiting

Registered drug

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Domvanalimab

Contact Research Centre

Prostate cancer metastatic

Not recruiting

Registered drug

Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Small cell lung cancer extensive stage

Not recruiting

Registered drugNo placebo

Study on the Effect of Adding Thoracic Radiotherapy to Durvalumab and Chemotherapy for Patients with Extensive Stage Small-Cell Lung Cancer

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Follicular lymphoma+2

Not recruiting

InvestigationalNo placebo

Study of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma

InvestigationalNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Mosunetuzumab

Contact Research Centre

Find therapies in clinical trials near you

12 trials match your criteria

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Coeliac disease

Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

Colitis ulcerative

Efficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis

Non-small cell lung cancer

Study on the Safety and Effectiveness of Nivolumab, Pembrolizumab, and Cemiplimab with Radiotherapy for Stage IV Non-Small Cell Lung Cancer Patients

Crohn's disease

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease

Deafness neurosensory

Study of Hyperbaric Oxygen Therapy Combined with Standard Treatment for Patients with Sudden Hearing Loss

Diffuse large B-cell lymphoma refractory

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Primary adrenal insufficiency

Study on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone

Lung neoplasm malignant

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Prostate cancer metastatic

Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

Small cell lung cancer extensive stage

Study on the Effect of Adding Thoracic Radiotherapy to Durvalumab and Chemotherapy for Patients with Extensive Stage Small-Cell Lung Cancer

Follicular lymphoma+2

Study of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.